[Federal Register Volume 71, Number 211 (Wednesday, November 1, 2006)]
[Notices]
[Page 64298]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-18375]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on August 28, 2006, Cambrex 
Charles City, Inc., 1205 11th Street, Charles City, Iowa 50616, made 
application by letter to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of Sufentanil (9740), a basic 
class of controlled substance listed in schedule II.
    The company plans to manufacture the listed controlled substance in 
bulk for distribution to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537, Attention: DEA Federal Register 
Representative/ODL; or any being sent via express mail should be sent 
to DEA Headquarters, Attention: DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must 
be filed no later than January 2, 2007.

    Dated: October 25, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E6-18375 Filed 10-31-06; 8:45 am]
BILLING CODE 4410-09-P